Cutting-Edge Structural Interventions | MitraClip Anterior Leaflet Laceration: Electrosurgical Technique For Failed Clip?
(WorldNews Health)

The treatment of mitral regurgitation has been revolutionized by the MitraClip device (Abbott Vascular, Chicago, IL). While originally approved only for patients with primary mitral valve disease and no surgical options, the recent COAPT trial has led to an expanded indication for patients with heart failure and secondary mitral regurgitation despite optimization of guideline-directed medical and device therapy.1 Patients with persistent residual or recurrent mitral regurgitation following MitraClip placement present a challenging clinical scenario to the Heart Team. As patients undergoing MitraClip therapy for secondary mitral regurgitation are nonsurgical candidates prior to initial...